Alzamend Neuro (ALZN) traded up 0.89 % during a 24 hours period ending at 07:32 PM Central Europe on Monday 26th. One Alzamend Neuro stock can currently be bought for about USD 1.12 on popular exchanges. Current supply of Alzamend Neuro stocks is 4.8 mn. Alzamend Neuro has a current market capitalization of USD 5.5 mn and approximately USD 32.9 k worth of Alzamend Neuro was traded on exchanges in the last 24 hours. Since last month end, Alzamend Neuro has traded -37.91 % down. Simple moving average of last 200 days is at USD 1.5. The highest price of past 52 weeks was recorded at USD 2.68 on 10/31/2025. 52 weeks low was at USD 0.84 on 04/13/2026.
Here is how related stocks have performed in the past 24 hours:
Tenon Medical (TNON) traded down -1.79 % and now trades at USD 2.13. Current market capitalisation for Tenon Medical is USD 5.9 mn.
Arrive Ai (ARAI) traded down -8.66 % and now trades at USD 0.11. Current market capitalisation for Arrive Ai is USD 6 mn.
Aprea Therapeutics (APRE) traded down -4.43 % and now trades at USD 0.44. Aprea Therapeutics has a market capitalisation of USD 6.5 mn.
Posabit (PBIT.CN) traded down -21.43 % and now trades at CAD 0.06. Current market capitalisation for Posabit is CAD 8.9 mn.
Enveric Biosciences (ENVB) traded down -4.11 % and now trades at USD 1.37. Current market capitalisation for Enveric Biosciences is USD 6.3 mn.
About Alzamend Neuro
Alzamend Neuro, Inc. is a bio-pharmaceutical company based in Atlanta, United States. The company specializes in developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders while also providing research and testing services. Alzamend Neuro serves customers worldwide and can be accessed through their website at www.alzamend.com . The company’s stock is traded on the Nasdaq.